CVS closing down clinical trials business after 2 years
2023-05-15
并购临床研究疫苗
Preview
来源: FierceHealthcare
Clinical trials were a major topic of conversation nationally at the height of the COVID-19 pandemic as new vaccines and therapies to treat the virus.
CVS Health is closing down its clinical trials arm just two years after its launch, a company spokesperson confirmed to Fierce Healthcare.
The spokesperson said the healthcare giant routinely reviews its portfolio to ensure its assets are "aligned with our long-term strategic priorities." The company will wind down Clinical Trial Services in "a phased way" and expects a full exit by Dec. 31, 2024.
"In parallel, we’re working to support impacted colleagues, and will provide career transition support for those unable to find another role within CVS Health," the spokesperson said.
CVS unveiled Clinical Trial Services in May 2021 in a bid to drive greater participation in clinical trials, as Fierce Healthcare previously reported. The unit's leadership at the time said the work built upon CVS' existing relationship with drugmakers and its efforts to build community relationships.
Clinical trials were a major topic of conversation nationally at the height of the COVID-19 pandemic as new vaccines and therapies emerged to treat the virus. It also put a spotlight on the lack of diversity historically in clinical trials, as people of color were disproportionately impacted by the pandemic but tend to be underrepresented in drug trials.
CVS is in the midst of bringing two key acquisitions into the fold: Signify Health and Oak Street Health. The company said on its earnings call earlier this month that these two companies are critical in its aspirations in the primary care space.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。